Skip to main content
Top
Published in: Clinical Rheumatology 10/2008

01-10-2008 | Case Report

Asymmetric scleroderma in a CVA patient

Authors: V. F. Azevedo, C. Mueller, S. C. Aragão

Published in: Clinical Rheumatology | Issue 10/2008

Login to get access

Abstract

We describe a systemic sclerosis and cerebral vascular accident case in which the cutaneous manifestation and the distal acroosteolysis occurred in an asymmetrical way in the non-paretic limb. The subsequent sclerodermic alterations and the acroosteolysis acquired an asymmetric pattern, sparing the patient’s hemiparetic side. Although a number of definitions of this protective effect may be found in other rheumatic diseases, such as rheumatoid arthritis and gout, we found in the literature only one previous case describing the protective effect of the hemiplegia in scleroderma.
Literature
1.
go back to reference Sethi S, Sequeira W (1990) Sparing effect of hemiplegia on scleroderma. Ann Rheum Dis 49:999–1000PubMedCrossRef Sethi S, Sequeira W (1990) Sparing effect of hemiplegia on scleroderma. Ann Rheum Dis 49:999–1000PubMedCrossRef
2.
go back to reference Thomason M, Bywater EGC (1962) Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 21:370–377CrossRef Thomason M, Bywater EGC (1962) Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 21:370–377CrossRef
3.
go back to reference Glick EN (1967) Assymetrical rheumatoid arthritis following polio. Braz Med J ii:26–29 Glick EN (1967) Assymetrical rheumatoid arthritis following polio. Braz Med J ii:26–29
4.
go back to reference Hamilton S (1983) Unilateral rheumatoid arthritis in hemiplegia. J Can Assoc Radiol 34:49–50PubMed Hamilton S (1983) Unilateral rheumatoid arthritis in hemiplegia. J Can Assoc Radiol 34:49–50PubMed
5.
go back to reference Mizushima Y, Yamura M (1969) Arthropathy and inflammatory reaction in hemiplegic patients. Acta Rheumatol Scand 15:297–304PubMed Mizushima Y, Yamura M (1969) Arthropathy and inflammatory reaction in hemiplegic patients. Acta Rheumatol Scand 15:297–304PubMed
6.
go back to reference Levine JD, Collier DH, Bassaum AI, Maskowitz A, Helms LA (1985) Hypothesis: the nervous system may contribute to the pathophysiology in rheumatoid arthritis. J Rheumatol 12:406–411PubMed Levine JD, Collier DH, Bassaum AI, Maskowitz A, Helms LA (1985) Hypothesis: the nervous system may contribute to the pathophysiology in rheumatoid arthritis. J Rheumatol 12:406–411PubMed
7.
go back to reference Pattrick M, Doherty M, Dieppe P (1984) Unilateral exacerbation of rheumatoid arthritis by hemiparesis. Braz J Rheumatol 23:107–109CrossRef Pattrick M, Doherty M, Dieppe P (1984) Unilateral exacerbation of rheumatoid arthritis by hemiparesis. Braz J Rheumatol 23:107–109CrossRef
8.
go back to reference Decaris E, Guingamp C, Chat M, Philippe L, Grillasca JP, Abid A et al (1999) Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum 42:1951–1960PubMedCrossRef Decaris E, Guingamp C, Chat M, Philippe L, Grillasca JP, Abid A et al (1999) Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum 42:1951–1960PubMedCrossRef
9.
go back to reference Eto F, Yoshikawa M, Ueda S, Hirai S (1980) Posthemiplegic shoulder-hand syndrome, with special reference do related cerebral localization. J Am Geriat Soc 28:13–17PubMed Eto F, Yoshikawa M, Ueda S, Hirai S (1980) Posthemiplegic shoulder-hand syndrome, with special reference do related cerebral localization. J Am Geriat Soc 28:13–17PubMed
10.
go back to reference Baerwald CG, Panayi GS (1997) Neurohumoral mechanisms in rheumatoid arthritis. Scand J Rheumatol 26:1–3PubMedCrossRef Baerwald CG, Panayi GS (1997) Neurohumoral mechanisms in rheumatoid arthritis. Scand J Rheumatol 26:1–3PubMedCrossRef
11.
go back to reference Tarkowski E, Naver H, Wallin BG, Blomstrand C, Tarkowski A (1995) Lateralization of T-lymphocyte responses in patients with stroke. Stroke 26:57–62PubMed Tarkowski E, Naver H, Wallin BG, Blomstrand C, Tarkowski A (1995) Lateralization of T-lymphocyte responses in patients with stroke. Stroke 26:57–62PubMed
12.
go back to reference Tarkowski E, Ekelund P, Tarkowski A (1991) Enhancement of antigen-specific T-cell reactivity on the affected side in stroke patients. J Neuroimmunol 34:61–67PubMedCrossRef Tarkowski E, Ekelund P, Tarkowski A (1991) Enhancement of antigen-specific T-cell reactivity on the affected side in stroke patients. J Neuroimmunol 34:61–67PubMedCrossRef
13.
go back to reference Tarkowski E, Jensen C, Ekholm S, Ekelund P, Blomstrand C, Tarkwowski A (1998) Localization of the brain lesion affects the lateralization of T-Lymphocyte cutaneous inflammation. Evidence for an immunoregulatory role of the right frontal cortex-putamen region. Scand J Immunol 47:30–36PubMedCrossRef Tarkowski E, Jensen C, Ekholm S, Ekelund P, Blomstrand C, Tarkwowski A (1998) Localization of the brain lesion affects the lateralization of T-Lymphocyte cutaneous inflammation. Evidence for an immunoregulatory role of the right frontal cortex-putamen region. Scand J Immunol 47:30–36PubMedCrossRef
14.
go back to reference Devi RS, Namasivayam A (1991) Modulation of the specific immunity by ventral hippocampal formation in albino rats. J Neuroimmunol 31:1–6CrossRef Devi RS, Namasivayam A (1991) Modulation of the specific immunity by ventral hippocampal formation in albino rats. J Neuroimmunol 31:1–6CrossRef
15.
go back to reference De Groot J (Ed) (1991) Correlative neuroanatomy. Appleton and Lange Press, California, pp 92–97 De Groot J (Ed) (1991) Correlative neuroanatomy. Appleton and Lange Press, California, pp 92–97
16.
go back to reference Tarkowski E, Blomstrand C, Tarkowski A (1995) Stroke induced lateralization of delayed-type hypersensitivity in the early and chronic phase of the disease: a prospective study. J Clin Lab Immunol 46(2):73–83PubMed Tarkowski E, Blomstrand C, Tarkowski A (1995) Stroke induced lateralization of delayed-type hypersensitivity in the early and chronic phase of the disease: a prospective study. J Clin Lab Immunol 46(2):73–83PubMed
17.
go back to reference Klippel JH (Ed) (2001) Primer on the rheumatic diseases, 12th edn. Arthritis Foundation, Atlanta, pp 353–357 Klippel JH (Ed) (2001) Primer on the rheumatic diseases, 12th edn. Arthritis Foundation, Atlanta, pp 353–357
Metadata
Title
Asymmetric scleroderma in a CVA patient
Authors
V. F. Azevedo
C. Mueller
S. C. Aragão
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 10/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0915-z

Other articles of this Issue 10/2008

Clinical Rheumatology 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine